Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $12.8 Million - $15.7 Million
-51,520 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$194.77 - $324.21 $10 Million - $16.7 Million
51,520 New
51,520 $14.9 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.32B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Berkshire Capital Holdings Inc Portfolio

Follow Berkshire Capital Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Capital Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Capital Holdings Inc with notifications on news.